S&P 500   3,111.15 (-0.29%)
DOW   27,827.42 (-0.38%)
QQQ   202.68 (-0.34%)
CGC   17.78 (+16.06%)
T   36.59 (-3.71%)
ACB   2.67 (+14.08%)
F   8.79 (-1.35%)
PRI   132.68 (+0.79%)
BAC   32.76 (-0.55%)
DIS   147.49 (-0.60%)
S&P 500   3,111.15 (-0.29%)
DOW   27,827.42 (-0.38%)
QQQ   202.68 (-0.34%)
CGC   17.78 (+16.06%)
T   36.59 (-3.71%)
ACB   2.67 (+14.08%)
F   8.79 (-1.35%)
PRI   132.68 (+0.79%)
BAC   32.76 (-0.55%)
DIS   147.49 (-0.60%)
S&P 500   3,111.15 (-0.29%)
DOW   27,827.42 (-0.38%)
QQQ   202.68 (-0.34%)
CGC   17.78 (+16.06%)
T   36.59 (-3.71%)
ACB   2.67 (+14.08%)
F   8.79 (-1.35%)
PRI   132.68 (+0.79%)
BAC   32.76 (-0.55%)
DIS   147.49 (-0.60%)
S&P 500   3,111.15 (-0.29%)
DOW   27,827.42 (-0.38%)
QQQ   202.68 (-0.34%)
CGC   17.78 (+16.06%)
T   36.59 (-3.71%)
ACB   2.67 (+14.08%)
F   8.79 (-1.35%)
PRI   132.68 (+0.79%)
BAC   32.76 (-0.55%)
DIS   147.49 (-0.60%)
Log in

iShares Nasdaq Biotechnology ETF Stock Price, Forecast & Analysis (NASDAQ:IBB)

$114.38
+0.93 (+0.82 %)
(As of 11/20/2019 12:58 PM ET)
Today's Range
$113.09
Now: $114.38
$114.62
50-Day Range
$97.01
MA: $105.17
$113.72
52-Week Range
$89.01
Now: $114.38
$116.25
Volume133,993 shs
Average Volume2.04 million shs
Market Capitalization$7.32 billion
P/E RatioN/A
Dividend Yield0.14%
Beta1.36
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. Read More…

Basic Details

Issuer iShares
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBB
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.23 billion
Average Daily Volume$2.08 million
Discount/Premium-0.06%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Receive IBB News and Ratings via Email

Sign-up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
Currency Exposure of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
Sector Exposure of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
Industry Exposure of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

What is iShares Nasdaq Biotechnology ETF's stock symbol?

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF announced a -- dividend on Tuesday, September 24th. Investors of record on Wednesday, September 25th will be given a dividend of $0.0715 per share on Monday, September 30th. This represents a dividend yield of 0.1%. The ex-dividend date is Tuesday, September 24th. View iShares Nasdaq Biotechnology ETF's Dividend History.

When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?

iShares Nasdaq Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Has iShares Nasdaq Biotechnology ETF been receiving favorable news coverage?

News articles about IBB stock have trended extremely negative this week, according to InfoTrie. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for iShares Nasdaq Biotechnology ETF.

Who are some of iShares Nasdaq Biotechnology ETF's key competitors?

What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Bank of America (BAC), Alibaba Group (BABA), Netflix (NFLX), Walt Disney (DIS), Tesla (TSLA), Gilead Sciences (GILD), Alphabet (GOOG), Boeing (BA) and JPMorgan Chase & Co. (JPM).

Who are iShares Nasdaq Biotechnology ETF's key executives?

iShares Nasdaq Biotechnology ETF's management team includes the folowing people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
  • Michael Arthur Latham, President, Trustee
  • Jack Gee, Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • , Bio & Compensation - 
  • Amy Schioldager, Executive Vice President
  • Ira P. Shapiro, Vice President, Chief Legal Officer
  • Matt Tucker, Vice President
  • , Bio & Compensation - 
  • Eilleen M. Clavere, Secretary
  • Cecilia H. Herbert, Independent Trustee
  • Charles A. Hurty, Independent Trustee

Who are iShares Nasdaq Biotechnology ETF's major shareholders?

iShares Nasdaq Biotechnology ETF's stock is owned by many different of institutional and retail investors. Top institutional investors include Commerzbank Aktiengesellschaft FI (0.41%), Great West Life Assurance Co. Can (0.27%), Commonwealth Equity Services LLC (0.24%), Tower Research Capital LLC TRC (0.21%), SG Americas Securities LLC (0.17%) and Tibra Equities Europe Ltd (0.14%).

Which major investors are selling iShares Nasdaq Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Tibra Equities Europe Ltd, Edge Wealth Management LLC, Avondale Wealth Management, Commerzbank Aktiengesellschaft FI, Calamos Advisors LLC, SG Americas Securities LLC, Commonwealth Equity Services LLC and Parkside Investments LLC.

Which major investors are buying iShares Nasdaq Biotechnology ETF stock?

IBB stock was bought by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC, 1 North Wealth Services LLC, Simplex Trading LLC, CAPROCK Group Inc., Tiedemann Advisors LLC, Park Avenue Securities LLC, John G Ullman & Associates Inc. and Fulton Breakefield Broenniman LLC.

How do I buy shares of iShares Nasdaq Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is iShares Nasdaq Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $114.14.

How big of a company is iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF has a market capitalization of $7.30 billion. View Additional Information About iShares Nasdaq Biotechnology ETF.


MarketBeat Community Rating for iShares Nasdaq Biotechnology ETF (NASDAQ IBB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  140 (Vote Outperform)
Underperform Votes:  133 (Vote Underperform)
Total Votes:  273
MarketBeat's community ratings are surveys of what our community members think about iShares Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe IBB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel